174 related articles for article (PubMed ID: 20565323)
21. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study.
Kohli R; Lo Y; Homel P; Flanigan TP; Gardner LI; Howard AA; Rompalo AM; Moskaleva G; Schuman P; Schoenbaum EE;
Clin Infect Dis; 2006 Jul; 43(1):90-8. PubMed ID: 16758423
[TBL] [Abstract][Full Text] [Related]
22. Injecting drug use is an independent risk factor for reincarceration after release from prison: A prospective cohort study.
Winter RJ; Stoové M; Agius PA; Hellard ME; Kinner SA
Drug Alcohol Rev; 2019 Mar; 38(3):254-263. PubMed ID: 30569550
[TBL] [Abstract][Full Text] [Related]
23. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.
Nachega JB; Hislop M; Dowdy DW; Chaisson RE; Regensberg L; Maartens G
Ann Intern Med; 2007 Apr; 146(8):564-73. PubMed ID: 17438315
[TBL] [Abstract][Full Text] [Related]
24. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
[TBL] [Abstract][Full Text] [Related]
25. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
26. Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d'Epidémiologie du SIDA en Aquitaine (GECSA).
Thiébaut R; Morlat P; Jacqmin-Gadda H; Neau D; Mercié P; Dabis F; Chêne G
AIDS; 2000 May; 14(8):971-8. PubMed ID: 10853978
[TBL] [Abstract][Full Text] [Related]
27. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study.
Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC
Vaccine; 2004 May; 22(15-16):2006-12. PubMed ID: 15121313
[TBL] [Abstract][Full Text] [Related]
28. Adherence to highly active antiretroviral therapy in HIV-infected inmates.
Inés SM; Moralejo L; Marcos M; Fuertes A; Luna G
Curr HIV Res; 2008 Mar; 6(2):164-70. PubMed ID: 18336264
[TBL] [Abstract][Full Text] [Related]
29. Association of Mental Health Services Access and Reincarceration Among Adults Released From Prison in British Columbia, Canada.
Palis H; Hu K; Rioux W; Korchinski M; Young P; Greiner L; Nicholls T; Slaunwhite A
JAMA Netw Open; 2022 Dec; 5(12):e2247146. PubMed ID: 36520435
[TBL] [Abstract][Full Text] [Related]
30. Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.
Demeter LM; Hughes MD; Coombs RW; Jackson JB; Grimes JM; Bosch RJ; Fiscus SA; Spector SA; Squires KE; Fischl MA; Hammer SM
Ann Intern Med; 2001 Dec; 135(11):954-64. PubMed ID: 11730396
[TBL] [Abstract][Full Text] [Related]
31. HIV treatment and care among Italian inmates: a one-month point survey.
Monarca R; Madeddu G; Ranieri R; Carbonara S; Leo G; Sardo M; Choroma F; Casari S; Marri D; Muredda AA; Nava FA; Babudieri S;
BMC Infect Dis; 2015 Dec; 15():562. PubMed ID: 26653247
[TBL] [Abstract][Full Text] [Related]
32. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
[TBL] [Abstract][Full Text] [Related]
33. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
34. An ecosystem-based intervention to reduce HIV transmission risk and increase medication adherence among inmates being released to the community.
Reznick OG; McCartney K; Gregorich SE; Zack B; Feaster DJ
J Correct Health Care; 2013 Jul; 19(3):178-93. PubMed ID: 23657796
[TBL] [Abstract][Full Text] [Related]
35. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
Ledergerber B; Egger M; Erard V; Weber R; Hirschel B; Furrer H; Battegay M; Vernazza P; Bernasconi E; Opravil M; Kaufmann D; Sudre P; Francioli P; Telenti A
JAMA; 1999 Dec; 282(23):2220-6. PubMed ID: 10605973
[TBL] [Abstract][Full Text] [Related]
36. Adherence to antiretroviral therapy among HIV-infected prisoners: a systematic review and meta-analysis.
Uthman OA; Oladimeji O; Nduka C
AIDS Care; 2017 Apr; 29(4):489-497. PubMed ID: 27582186
[TBL] [Abstract][Full Text] [Related]
37. Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
Kim S; Hughes MD; Hammer SM; Jackson JB; DeGruttola V; Katzenstein DA
AIDS Res Hum Retroviruses; 2000 May; 16(7):645-53. PubMed ID: 10791875
[TBL] [Abstract][Full Text] [Related]
38. Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study.
Erb P; Battegay M; Zimmerli W; Rickenbach M; Egger M
Arch Intern Med; 2000 Apr; 160(8):1134-40. PubMed ID: 10789606
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C and progression of HIV disease.
Sulkowski MS; Moore RD; Mehta SH; Chaisson RE; Thomas DL
JAMA; 2002 Jul; 288(2):199-206. PubMed ID: 12095384
[TBL] [Abstract][Full Text] [Related]
40. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.
Phillips AN; Staszewski S; Weber R; Kirk O; Francioli P; Miller V; Vernazza P; Lundgren JD; Ledergerber B; ; ;
JAMA; 2001 Nov; 286(20):2560-7. PubMed ID: 11722270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
